Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Graft vs Host Disease | Phase 1/Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Juvenile; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Myeloid | Phase 2 | ClinicalTrials |
| Liver Diseases | Phase 4 | ClinicalTrials |
| Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Waldenstrom Macroglobulinemia | Phase 1 | ClinicalTrials |
| Death; Kidney Failure, Chronic | Phase 4 | ClinicalTrials |
| Anemia; Anemia, Aplastic | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid, Acute; Lymphoma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 2 | ClinicalTrials |
| Leukemia; Lymphoma | Phase 2 | ClinicalTrials |
| Hematologic Neoplasms; Neoplasms | Phase 3 | ClinicalTrials |
| Immunologic Deficiency Syndromes; Severe Combined Immunodeficiency | Phase 1/Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 1/Phase 2 | ClinicalTrials |
| Graft vs Host Disease | Phase 2 | ClinicalTrials |
| Anemia; Fanconi Anemia; Fanconi Syndrome; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes | Phase 2 | ClinicalTrials |
| Anemia; Fanconi Anemia; Fanconi Syndrome; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 3 | ClinicalTrials |
| Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 2 | ClinicalTrials |
| Anemia; Anemia, Aplastic | Phase 2 | ClinicalTrials |
| Anemia; Anemia, Aplastic | Phase 2 | ClinicalTrials |
| Anemia; Anemia, Aplastic; Neutropenia; Pancytopenia; Thrombocytopenia | Phase 2 | ClinicalTrials |
| Hemoglobinuria; Hemoglobinuria, Paroxysmal; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Juvenile; Lymphoma; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 2 | ClinicalTrials |
CONTENTS